An immunological signature to predict outcome in patients with triple-negative breast cancer with residual disease after neoadjuvant chemotherapy
一种用于预测新辅助化疗后仍有残留病灶的三阴性乳腺癌患者预后的免疫学特征
期刊:ESMO Open
影响因子:8.3
doi:10.1016/j.esmoop.2022.100502
Blaye, C; Darbo, É; Debled, M; Brouste, V; Vélasco, V; Pinard, C; Larmonier, N; Pellegrin, I; Tarricone, A; Arnedos, M; Commeny, J; Bonnefoi, H; Larmonier, C; MacGrogan, G
